1. Lower Methylation of Glucocorticoid Receptor Gene Promoter 1F in Peripheral Blood of Veterans with Posttraumatic Stress Disorder
- Author
-
Amy Lehrner, Charles R. Marmar, Michael J. Meaney, Iouri Makotkine, Clare Henn-Haase, Linda M. Bierer, Frank Desarnaud, Rachel Yehuda, Janine D. Flory, and Nikolaos P. Daskalakis
- Subjects
Adult ,Male ,medicine.medical_specialty ,Hydrocortisone ,Hypothalamus ,Pituitary-Adrenal System ,Peripheral blood mononuclear cell ,Dexamethasone ,Monocytes ,Epigenesis, Genetic ,Stress Disorders, Post-Traumatic ,Cytosine ,Receptors, Glucocorticoid ,Glucocorticoid receptor ,Internal medicine ,medicine ,Humans ,Epigenetics ,Promoter Regions, Genetic ,Biological Psychiatry ,Veterans ,Depressive Disorder, Major ,Promoter ,Methylation ,DNA Methylation ,Endocrinology ,Dexamethasone suppression test ,DNA methylation ,Immunology ,Muramidase ,Psychology ,Biomarkers ,Glucocorticoid ,medicine.drug - Abstract
Background Enhanced glucocorticoid receptor (GR) sensitivity is present in people with posttraumatic stress disorder (PTSD), but the molecular mechanisms of GR sensitivity are not understood. Epigenetic factors have emerged as one potential mechanism that account for how trauma exposure leads to sustained PTSD symptoms given that PTSD develops in only a subset of trauma survivors. Methods Cytosine methylation of a relevant promoter of the GR gene ( NR3C1 -1 F promoter) and three functional neuroendocrine markers of hypothalamic-pituitary-adrenal axis function were examined in a sample of 122 combat veterans. Results Lower NR3C1 -1 F promoter methylation in peripheral blood mononuclear cells (PBMCs) was observed in combat veterans with PTSD compared with combat-exposed veterans who did not develop PTSD. NR3C1 -1 F promoter methylation was also associated with three functional measures of glucocorticoid activity that have been associated with PTSD in combat veterans: PBMCs' lysozyme inhibition on the lysozyme suppression test, plasma cortisol decline on the low-dose (.50 mg) dexamethasone suppression test, and 24-hour urinary cortisol excretion. Finally, NR3C1 -1 F promoter methylation was inversely correlated with clinical markers and symptoms associated with PTSD. Conclusions Alterations in NR3C1 -1 F promoter methylation may reflect enduring changes resulting from combat exposure that lead to functional neuroendocrine alterations. Because epigenetic measures are thought to reflect enduring effects of environmental exposures, they may be useful in distinguishing combat-exposed veterans who do or do not develop PTSD.
- Published
- 2015
- Full Text
- View/download PDF